Synairgen PLC (LSE:SNG) - Share price - Overview

Stock Report

Synairgen PLC SNG

Last Price
GBX10.25

Day Change
0.00|0.00%

As of 26/05/2017
08:10:50 BST | GBX
Minimum 15 Minutes Delay.

Last Close10.25p
Day Range10.50 - 10.50
Mkt Cap9.37Mil
52-Wk Range7.00 - 37.90
Yield %0.00
ISINGB00B0381Z20
Volume40,000
P/E-3.33
P/S379.63
P/CF-4.99

Share Price

Total Returns 26/05/2017

 Chg (%)  
More ...
Synairgen PLC-60.58 
FTSE 100 TR GBP4.15
 
Financials
201420152016
More ...
Income Statement
Turnover4.290.03-
Operating Profit1.09-2.61-
Net Profit1.19-2.26-
Reported EPS1.35-2.47-
Balance Sheet
Current Assets9.818.19-
Non Current Assets0.120.10-
Total Assets9.938.28-
Current Liabilities0.500.94-
Total Liabilities0.500.94-
Total Equity9.447.35-
Cash Flow
Operating Cash Flow1.61-1.99-
Net Change in Cash2.011.15-
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-3.56-3.37--3.04---
20180.881.32-7.77---

Regulatory News

DateSourceHeadline
More ...
17/05/2017|07:00RNSSynairgen plc - Preliminary Results
27/04/2017|07:00RNSSynairgen plc - AZD9412 Update
27/03/2017|07:00RNSSynairgen plc - Holding(s) in Company

Company Profile

Synairgen PLC through its subsidiaries is engaged in discovery and development of respiratory drugs for lung antiviral defense in asthma, COPD and severe viral infections.

Sector

Biotechnology

Market Position

1539 of 1851 Companies

Index

FTSE AIM All Share

Outlook

(17/05/2017) no outlook statement

Next Event 14/06/2017

Next AGM
Ratios
CompSecMkt
More ...
PER (E)-6.8015.0716.87
Div Yld (E)0.003.604.05
PEG (E)0.000.420.72
ROCE0.00187.8415.97
Op Mrgn0.00-6.501.61
EPS Grwth0.0056.9427.17
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Simon Shaw
Chief Executive OfficerRichard Marsden
Finance Director & Company SecretaryJohn Ward
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.